INHIBRX, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 34.11 USD | +0.09% |
|
-0.70% | -10.24% |
| May. 31 | Inhibrx, Inc.(NasdaqGM:INBX) dropped from S&P Biotechnology Select Industry Index | CI |
| May. 31 | Inhibrx, Inc.(NasdaqGM:INBX) dropped from S&P Global BMI Index | CI |
Business Summary
Number of employees: 169
Sales per Business
| USD in Million | 2022 | Weight | 2023 | Weight | Delta |
|---|---|---|---|---|---|
Biological Therapeutic Candidates
100.0
%
| 2 | 100.0 % | 2 | 100.0 % | -17.88% |
Sales per region
| USD in Million | 2022 | Weight | 2023 | Weight | Delta |
|---|---|---|---|---|---|
United States
100.0
%
| 2 | 100.0 % | 2 | 100.0 % | -17.88% |
Share class
| Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
|---|---|---|---|---|---|
| Stock A | 1 | 52,401,941 | 38,872,072 ( 74.18 %) | 0 | 74.18 % |
Company contact information
Inhibrx, Inc.
11025 North Torrey Pines Road Suite 200
92037, La Jolla
+858 795 4220
http://www.inhibrx.com
Sector
Sell
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
34.11
USD
Average target price
35.5
USD
Spread / Average Target
+4.08%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -10.24% | 1.79B | |
| +11.91% | 118B | |
| +11.60% | 106B | |
| -4.68% | 24.28B | |
| -0.82% | 21.96B | |
| -10.12% | 18.16B | |
| -42.12% | 16.37B | |
| -17.47% | 15.56B | |
| +2.77% | 13.63B | |
| +34.58% | 12.27B |
- Stock Market
- Equities
- INBX Stock
- Company Inhibrx, Inc.
